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The role of His145 in the T1 copper center of Nitrite Reductase (NiR) is pivotal for the activity of the 
enzyme. Mutation to a glycine at this position enables the reconstitution of the T1 center by the 
addition of imidazole as exogenous ligands, however the catalytic activity is only marginally rescued. 
Here we demonstrate that the uptake of 1,3-dimethylimidazolylidene as N-heterocyclic carbene 
(NHC) by the H145G NiR mutant instead of imidazole yields a significantly more active catalyst, 
suggesting a beneficial role of such C-bonding. Spectroscopic analyses of the formed H145G~NHC 
variant as well as an analogue without the catalytic T2 copper center reveals no significant alteration 
of the T1 site compared to the wild type or the variant containing imidazole as exogenous N-bound 
surrogate of H145. However, the presence of the carbene doubles the catalytic activity of the mutant 
compared to the imidazole variant. This enhanced activity has been attributed to a faster electron 








Carbenes, a two valence electron-neutral carbon species, and in particular N-heterocyclic 
carbenes (NHCs), have been key moieties employed in the design of metal-based catalysts, which 
allow for the modulation of the activity and selectivity of the metal center.[1–3] Despite the compelling 
properties imparted by the carbon-coordination mode, examples of such species in biologically-
relevant systems are rare,[4] and no naturally occurring carbenes have been observed as coordinating 
ligands in metalloproteins. The only examples of NHC-metal coordination in biologically-relevant 
environments have been imposed by combining synthetic catalysts with protein scaffolds to generate 
hybrid enzymes, which exploit the promiscuous activity provided by the metal center and the regio- 
and/or stereo-selective properties imparted by the peptide structure.[5–7] Very recently, however, 
carbene-metal binding was observed in fully natural enzymes as intermediate step in the enzymatic 
C–H functionalization catalyzed by iron hemoproteins.[8,9] 
In this context, we exploited a small copper protein, the Azurin from P. aeruginosa, to 
demonstrate that carbene coordination facilitates reduction processes at the Cu center. The solvent 
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exposed coordinating histidine of the T1 Cu-center was substituted with an exogenous NHC ligand, 
which successfully restores the spectroscopic properties and decreases the redox potential.[10] 
Furthermore, we speculated that the tautomerization of imidazole to NHC occurring in the histidine 
ring might act as switch to modulate the catalytic events in some metallo-enzymes. Histidine is indeed 
a common amino acid often exploited as metal coordination moiety at the active site of enzymes and 
binds to a metal center through the nitrogen of its imidazole ring.[11,12] In hemoproteins, for example, 
the axial binding of histidine to the heme prosthetic group controls the reactivity of the metal center 
and triggers the binding and release of small molecules, such as O2, in the trans position.[13] Generally 
histidine is considered to bind through a side chain nitrogen to the metal center, and this bonding 
mode has been established through countless spectroscopic and crystallographic studies.[14] The 
alternate carbon-coordination offers a rationale for those electron transfer and catalytic processes 
that occur at low redox potentials. Therefore, we expanded our approach to a catalytically active Cu-
enzyme to probe the influence of a NHC ligand on the enzymatic properties.  
Cu-containing proteins mediate numerous electron transfer processes, yet they operate over a 
broader redox range than their standard reduction potentials would suggest.[14–16] Azurin (Azu) and 
pseudo-azurin typically act as an electron shuttle to redox enzymes, such as nitrite reductase (NiR), 
which is found in the dissimilatory denitrification pathways of certain Alcaligenes sp. (A. faecalis and 
A. xylosoxidans), and Psudomonas genus among others.[17] Nitrite reductases possess two Cu centers 
in entatic states,[18,19] a T1 center that possesses a similar coordination sphere to the Cu center in Azu, 
and a type 2 (T2) center, buried in the enzyme structure where the reduction of NO2– to NO takes 
place (Fig 1A). In vivo, electrons are shuttled from the Azu-T1 to the NiR-T1 in a transient protein-
protein complex, and then from NiR-T1 to T2 where the substrate NO2– is eventually reduced to 
NO.[20–22] In the NiR from A. faecalis, mutations of the His145 ligand at the T1 Cu center result in 
variants that behave similarly to Azu-H117G. The His145 residue bridges the solvent-accessible area 
to the Cu center and allows for the coordination of an exogenous ligand to this T1 Cu site. In Azu, the 
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reconstitution is limited to the restoration of the UV/vis and EPR spectroscopic fingerprint, yet the 
lack of catalytic properties does not allow any further considerations.[23]  
In this work, we have prepared the H145G NiR mutant and introduced an NHC precursor to 
investigate the implications of a C-bound ligand at a T1 Cu-center of an active metallo-enzyme.[24] The 
enhanced activity of this NHC system compared to the imidazole-rescued analogue underpins the 
potential of these C-coordinated ligands in redox processes mediated by metallo-enzymes. Moreover, 
computational studies provided also insights on the stability of such a C-bonding mode of the 
imidazole heterocycle.  
 
Figure 1. A) Schematic representations of nitrite reductase (from A. faecalis – PDB 2FJS) and close up of the Cu binding sites, 
including the T1 Cu site involved in electron transfer and bound by the same set of amino acids as azurin, and the catalytic T2 
Cu site bound by three histidine ligands and engaged in the actual reduction of nitrite to nitric oxide. [25,26] B) Overlay of T1-Cu 
sites of the nitrite reductase (green) and the one of the small copper protein Azurin (from P. aeruginosa – PDB: 3U25, cyan). 
 
Results and Discussion 
1. Protein preparation and spectroscopic features 
Clones of the wild type (WT) and H145G variants of NiR harbored in a pET28a vector[26] were used 
as templates to generate a cleavable poly-His-tag version of both proteins through the introduction 
of a Tobacco Etch Virus (TEV) endopeptidase cleavage sequence. This approach led to an easy removal 
of the poly-histidine tail used for purification to avoid potential interference through coordination to 
Cu(II) ions. Samples of the WT and H145G mutant NiR were purified by single step metal affinity 
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chromatography (Figure S1), followed by poly-his tag cleavage using 50:1 TEV proteases, and buffer 
exchange by gel-filtration. Cleavage and structural integrity were verified by mass spectrometry 
(Figure S2). Due to the superimposition of the T1 and T2 signals in EPR spectroscopy, the catalytic T2 
copper center in NiR was silenced by modification of the bonding site through a H306A mutation, 
which is known to suppress copper binding to this site.[27] The NiR T2 mutants (H306A and H145G-
H306A) were successfully prepared following the same procedure (Figure S1, S2). 
 
Cu(II) binding  of the mutant in the presence of imidazole (H145G~Imid 3, Figure 2) was verified 
by UV-vis (Figure 3A) and EPR spectroscopy (Figure S11). Frozen solution X-band EPR spectroscopy at 
77 K revealed the classic signature of a reconstituted T1 Cu center (gǁ = 2.196, Aǁ = 76 ´ 10–4 cm–1, 
Table 1) superimposed with the unaltered resonance pattern of the internal T2 center (gǁ = 2.341, Aǁ 
= 156 ´ 10–4 cm–1). These observations are in excellent agreement with literature data and confirm 
that the H145G mutation does not significantly affect the structure of the protein and that the 
spectroscopic signatures can be restored upon coordination of imidazole (Imid).[28–30] 
 
 
Figure 2. Schematic representation of the T1 site of NiR WT (1), and the mutant H145G containing water (2), an imidazole (3), 
and a NHC (4) ligand as analogues of the N- and C-bonding modes of His, respectively. 
 
Following our previously established method,[10] dimethylimidazolium carboxylate (NHC-CO2) was 
used as precursor to install an exogenous carbene ligand at the T1 Cu center of NiR H145G 
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equiv) was used in the presence of the H145G~H2O mutant 2 in aqueous MES buffer pH 7. The addition 
of the carbene precursor induced a rapid color change of the protein in solution from a very light grey 
to intense green/grey color, identical to the change observed when reconstituting the T1 Cu center 
of the H145G~H2O mutant with exogenous Imid (Figure 3B). The UV-vis spectra of the WT and the 
H145G~Imid and H145G~NHC mutants are similar and feature three distinct absorption maxima at ca. 
390, 460, and 590 nm (e 1.5–3 mM–1 cm–1; Table 2, Figure 3). The maxima shift by less than 7 nm upon 
variation of exogeneous ligand, though the exact maxima are difficult to determine accurately due to 
the broadness of the absorption bands. In the absence of either NHC or Imid as exogenous ligand, 
H145G~H2O features two T2 copper centers with radically altered electronic spectra (three very broad 
and weak absorptions at 360, 450, and 600 nm, with extinction coefficients <1.0 mM–1 cm–1), 
providing a diagnostic tool to monitor Imid and NHC bonding to the mutant. It is notable that neither 
the NHC nor the Imid ligand fully reconstitute the T1 center. Reconstitution is estimated at 50% and 
75%, respectively, based on the extinction coefficient at lmax around 590 nm. Remarkably, the T2 
mutation (H306A) did not alter the UV-vis signature of the parent NiR construct, nor of the double 






Figure 3. A) UV-vis spectra of the wild-type, and the H145G mutant without any ligand (H2O; 2), with 
imidazole (Imid; 3) or N,N’-dimethylimidazolylidene (NHC; 4) coordinated to the copper site. The UV-vis 
spectra show the essentially identical absorption characteristics (lmax) of NiR WT and the H145G mutants 
restored with Imid or NHC. Spectra of NiR WT, NiRH145G~H2O and NiRH145G~Imid have been recorded 
for reference and fully agree with reported data.[23] The insets shows a expansion of the visible region in 
the 0–3 mM–1 cm–1 extinction coefficient range. B) Samples of NiR WT and H145G showing the diagnostic 
color of the variants upon addition of exogenous ligand.  
Table 1. Spectroscopic data for NiR wild-type and H145G and H306A mutants containing Imid and NHC as exogenous ligands a) 
 lmax 
(nm) 
 eapp b) 
(mM–1 cm–1) 
 g^ gǁ Aǁ 
(10–4 cm–1) 
 




















































































T1 2.060 2.197 68 
a) UV-vis spectra in MES buffer (10 mM MES, pH 7.0); X-band EPR spectra of frozen 0.5 mM protein solution in 
glycerol:MES buffer pH 7 (50:50 v/v%) at 77 K with a modulation amplitude of 5 G; b) apparent extinction 




N- and C-bonding of the exogenous ligands in the H145G mutant was further investigated by EPR 
spectroscopy. While in all constructs, the buried T2 Cu site remains essentially unchanged (Table 1, 
Figure S11), the signature of the peripheral Cu center is diagnostic. A distinct shift is observed 
between the WT and the H145G~H2O holo mutant, as the latter reveals a large hyperfine splitting 
indicative of a T2 Cu site. The binding of a carbene unit to the Cu center in this H145G mutant results 
in EPR spectroscopic data very similar to those of the WT and of the H145G~Imid mutant (Table 1, 
Figure S11), suggesting successful restoration of a T1 site. As observed in the UV traces, the EPR 
spectra confirm with remarkable accuracy the same level of reconstitution (50% for NHC, 69% for 
Imid). The EPR data are reminiscent of those observed for the azurin mutants, which is expected when 
considering the essentially identical structure and electronic configuration of the T1 site in both 
enzymes. The EPR spectra for the T2 mutant (H306A) could be simulated to unambiguously extract 





Figure 4. Stacked EPR spectra of NiR H306A and H306A-H145G mutants. H306A mutant (green trace) showing the clear T1 
features, H145G-H306A mutant without any ligand (H2O) and containing an imidazole ligand (Imid, 10 eq.) and an N-
heterocyclic carbene ligand (NHC, 10 eq.). Spectra of NiR H306A have been recorded for reference and fully agree with reported 
data.[27] Simulated spectra shown as dashed lines. 
 
To exclude alternative binding modes of the carboxylate-NHC precursor, a series of control 
ligands were investigated by UV-vis and EPR spectroscopy. These control ligands included i) 1,3-
dimethylimidazolium tetrafluoroborate (dMI) and 1,2,3-trimethyl-imidazolium tetrafluoroborate 
(tMI) to exclude the formation of  alternative carbene cordination modes, such as abnormal C4-bound 
carbenes or Cu–p interactions;[31] ii) sodium benzoate (Benz) to mimic the carboxylate binding that 
would be expected if decarboxylation in the NHC–CO2 precursor were inhibited (Figure S4, S9, S12; 
Table S2, S3); and iii) 1,2-dimethylimidazole (DMI) to probe the unexpected migration of a methyl 
group from nitrogen to the carbenic carbon. None of these control ligands was able to reproduce the 
WT features, supporting the NHC coordination mode to the T1 Cu-center in H145G~NHC. Of note, 
while DMI-binding to the H145G mutant was not detectable (Figure S5, S10; Table S2, S3), DMI showed 
a normal nitrogen binding behavior with the Azurin,[10] (Figure S16), with a coordination stability 
comparable to N-methyl imidazole (NMI; Figure S17). This could be due to the fact that while the NiR 
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and Azu T1 copper sites can be confidently overlaid, the NiR T1 site is buried deeper in the protein 
structure than in Azu. 
 
Interestingly, the UV-vis signature of H145G~NHC was stable for the first two hours after sample 
preparation (Figure S6), but it gradually lost intensity and bleaching was complete (ε < 0.4 mM-1 cm-1) 
within 48 h. This bleaching may be rationalized either by stripping of the Cu-NHC unit or with a reduction 
of the Cu(II) center to Cu(I) in the T1 site. To better understand this behavior, we replicated the bleaching 
conditions with Azurin,[10] which features essentially the same T1 Cu coordination (cf Fig. 1B), yet it has a 
much simpler UV-vis signature to monitor changes over time. Azurin was investigated under a range of 
conditions. The addition of fresh Cu(II) or Cu(II) and NMI to an aged and bleached sample (72 h) of 
AzuH117G~NHC did not rescue the UV-vis signature (Figure S13, S14), suggesting that the T1 site is either 
compromised[32,33] or still occupied. Therefore, a 72 h aged and bleached sample of AzuH117G~NHC was 
washed repeatedly with buffer to remove ions and labile ligands (see SI). The sample was then treated as 
if freshly purified, i.e. incubated with both Cu(II) and NMI. This procedure recovered the pertinent UV/vis 
features (lmax = 630 nm) and up to 77% of its original absorbance (ε72h =  3.4 mM-1 cm-1 vs εfresh = 4.4 mM-
1 cm-1),[10] indicating that the T1 site was almost completely accessible (Figure S15). The copper present in 
the samples and washing fractions was quantified by inductively coupled plasma mass spectrometry (ICP-
MS), which confirmed that the washed protein retained ~35% of the metal with respect to the unwashed 
sample. This partial retention explains why the washed sample did not regain the full intensity at 630 nm. 
These data suggest that the bleaching effect is due to Cu(II) to Cu(I) reduction promoted by the NHC 
binding and not due to alteration of the amino acid side chains of the T1 coordination site (e.g. cysteine 
oxidation). Further support for such a reduction was obtained from comparative EPR analyses of freshly 
prepared and aged samples of AzuH117G~NHC as well as the NiR analogue, which indicate the 
disappearance of the characteristic T1 signature, yet no formation of a T2 center or resonances due to 
dissolved Cu(II) ions were observed (Figure S18). Cu(I) binding to the T1 site is expected to be weaker than 
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Cu(II) binding, as indicated by the Cu content detected in the washing fractions (Table S6). In contrast to 
the C-bonding of NHC, analogous N-binding of an exogenous ligand by coordination of NMI to the 
AzuH117G copper mutant resulted in a sample that showed a much higher stability, losing only 20% of its 
intensity within the first 48 h (Figure S17). These findings lend strong support to the fact that NHC 
preferentially stabilizes low-valent Cu(I) centers while the N-ligand favors high-valent Cu(II) species.[34] 
Efforts to further probe this ligand impact by electrochemistry were unsuccessful, and despite numerous 
approaches (microelectrode, electrode coating), no reliable redox signal could be recorded.[35]  
Carbene bonding to the T1 copper site has been further probed theoretically using both the 
smaller Azu as well as NiR. In a first stage, small quantum chemical models for the Cu site of Azu were 
used, consisting of the residues Cys112, Met121 and His46 as well as the backbone carbonyl of Gly45, 
which acts as the fifth ligand to Cu. To validate the model, the original Azu active site containing 
His117 was considered as well. For the external ligands, an unsubstituted imidazole and an 
unsubstituted NHC were used to optimize two tautomers. In a second step, the effective ligands (NMI 
and NHC, respectively) were used to evaluate the stereochemical influence of the methyl groups on 
the binding modes. The construction of the protein model assumes that the H117G mutant follows 
the same folding pattern and maintains the Cu site relatively intact, as demonstrated experimentally. 
The calculated model is validated by the comparison of geometries and the correct reproduction of 
the ligand hyperfine coupling constants of the Azu WT within the limits of DFT (Table S7-S8, Figure 
S19). In silico introduction of the NHC induces only minimal geometrical changes and the T1 center is 
fully preserved. Remarkably, the NHC system is computed to have about the same energy as the NMI 
analogue. While the Azurin is a somewhat simplified model, the same analysis performed on the T1 
NiR yielded virtually identical results (Table S9-S10, Figure S20). In fact, due to the distortion of the 




Figure 5. Optimized QM model for the T1 site of the NiR H145G~NHC mutant. 
 
2. Enzymatic activity 
The catalytic relevance of carbene bonding in the NiR instead of a histidine in the WT was probed 
by monitoring the enzymatic reduction of nitrite (NO2–) to nitric oxide (NO).[20,23] Activity assays using 
methyl-viologen as sacrificial reducing agent showed a WT activity of 899 U mg–1, while the 
H145G~H2O mutant shows only marginal activity detectable above the background (Table 2 and Table 
S5 for complete raw data). Coordination of Imid as a His mimic induces an activity of 67 U mg–1, 
corresponding to a 12-fold reduction in activity with respect to the WT. These data are in agreement 
with previous investigations reported by Canters and co-workers who observed a 10-fold reduction 
in activity upon rescuing the H145G mutant with imidazole.[23] In contrast, C-coordination of the NHC 
ligand increases the catalytic activity to 111 U mg–1, a nearly 100% enhancement when compared to 
H145G~Imid. Due to the suboptimal occupancy achieved with both exogenous ligands, the measured 
activities are likely an underestimation of the full catalytic capacity of the rescued mutants, which 
when taking into account even the moderate contribution of the H145G~H2O activity, would even 
further enhance the effect of the NHC ligand. 
 
Table 2. Catalytic nitrite reduction activity for NiR wild-type and H145G mutants containing 
Imid and NHC as exogenous ligands. 
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 Activitya) 
WT 899 ± 89 
H145G~H2O 31 ± 5 
H145G~Imid 67 ± 14 
H145G~NHC 111 ± 4 
H306A no detectable activity 
a) activity in U mg–1 (units U as µmol NO2– reduced per minute, see materials and methods for details) 
 
The significant enhancement of catalytic activities of the NHC mutant compared to the Imid analogue 
tentatively suggest that changing the coordination mode of the N-heterocycle induces a shift in the 
rate limiting step, which is associated with the electron transfer process, i.e. the prime function of 
the peripheral T1 copper site. In the NiR WT, reversible oxidation and reduction of the T1 site is fast 
and promotes the shuttling of electrons from the sacrificial donor (Azu in the natural system, methyl 
viologen in the assay) to the catalytic T2 site.[20] With imidazole as a static N-bound ligand in the 
H145G~Imid variant, the T1 site is stabilized in its high-valent Cu(II) state. Assuming single electron 
transfer process to be generally fast in these enzymes (cf WT activity), this enhanced stabilization of 
the Cu(II) state limits electron transfer from the sacrificial donor to the T1 site and concomitant metal 
reduction to Cu(I). This step is substantially facilitated in the H145G~NHC mutant, since the softer 
carbene binding favors metal reduction to the lower-valent Cu(I) state (cf bleaching experiments and 
electrochemistry of Azu–NHC mutant).[31] While static carbene bonding stabilizes the Cu(I) state and 
therefore increases the barrier for re-oxidation of the T1 copper center, the enhanced catalytic 
activity of the NHC mutant indicates that this penalty is considerably lower than that of the reduction 
in the NMI variant (Figure 5). This higher barrier rationalizes the lower activity of the NHC mutant 
compared to the WT. Such a mechanistic model therefore suggests that static ligand bonding is 
favoring the T1 center either as high-valent Cu(II) (N-bonding of Imid) or as low-valent Cu(I) (C-




Figure 6. Schematic mode of action of NiR indicating the steps proposed to be promoted for the H145G~NHC variant 




Here we have successfully introduced an exogeneous NHC ligand to the NiR H145G mutant, which 
reconstitutes the spectroscopic properties of the NiR WT. This new NiR H145G~NHC variant 
constitutes a rare example of a blue copper protein containing a carbene ligand. Bleaching of the 
diagnostic green color has been demonstrated to occur due to reduction of the copper center from 
Cu(II) to Cu(I). This reactivity pattern is not observed with N-bound ligands such as His or imidazole, 
and suggests stabilization of low-valent Cu(I) by the NHC ligand, in good agreement with earlier 
electrochemical analysis of the Azu mutants showing easier reduction of Azu–Cu(NHC) than Azu–
Cu(NMI). This propensity to stabilize low oxidation state Cu(I) also has a direct impact on the catalytic 
performance of NiR in nitrite reduction, as the rate limiting step is proposed to be shifted to re-
oxidation of the T1 copper site while electron transfer to the catalytic Cu center is fast and results in 
twice as high catalytic activity as compared to the imidazole-reconstituted variant. The benefit of 
carbene bonding would be greatly exploited if it were possible to engineer an amino acid with a 
carbene precursor side chain and devise a tRNA/aaRS system for genetic incorporation via AMBER 
stop-codon suppression[36] of this non-natural ligand in metalloenzyme active sites. Moreover, the 
 15 
fact that neither C-bonding nor N-bonding impart the activity of the WT, yet shift the rate limiting 
step, deserves further consideration and opens up the possibility that His could undergo transient 
tautomerism in metalloenzyme active sites during the catalytic cycle. This alternative C-bonding may 
be established by reversible wagging of His to induce tautomerization between the C- and N-bonding 
mode. Such tautomerization may be particularly relevant for redox-active metallo-enzymes 
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